Skip to content
The Mumbai

OneSource Specialty Pharma Reports Strong Q2 FY27 With 37% Revenue Growth, Adjusted PAT Doubles

OneSource Specialty Pharma Reports Strong Q2 FY27 With 37% Revenue Growth, Adjusted PAT Doubles
Photo: Free Press Journal · view original

Mumbai: OneSource Specialty Pharma Ltd on Tuesday reported its consolidated financial results for the quarter ended September 30, 2026. The company's revenue rose to ₹516.2 crore, marking a 37 per cent increase year-on-year and a 15 per cent rise quarter-on-quarter. Financial Performance EBITDA f...

Sources and story details